Müller cells trophism and pathology as the next therapeutic targets for retinal diseases
- PMID: 40254246
- DOI: 10.1016/j.preteyeres.2025.101357
Müller cells trophism and pathology as the next therapeutic targets for retinal diseases
Abstract
Müller cells are a crucial retinal cell type involved in multiple regulatory processes and functions that are essential for retinal health and functionality. Acting as structural and functional support for retinal neurons and photoreceptors, Müller cells produce growth factors, regulate ion and fluid homeostasis, and facilitate neuronal signaling. They play a pivotal role in retinal morphogenesis and cell differentiation, significantly contributing to macular development. Due to their radial morphology and unique cytoskeletal organization, Müller cells act as optical fibers, efficiently channeling photons directly to the photoreceptors. In response to retinal damage, Müller cells undergo specific gene expression and functional changes that serve as a first line of defense for neurons, but can also lead to unwarranted cell dysfunction, contributing to cell death and neurodegeneration. In some species, Müller cells can reactivate their developmental program, promoting retinal regeneration and plasticity-a remarkable ability that holds promising therapeutic potential if harnessed in mammals. The crucial and multifaceted roles of Müller cells-that we propose to collectively call "Müller cells trophism"-highlight the necessity of maintaining their functionality. Dysfunction of Müller cells, termed "Müller cells pathology," has been associated with a plethora of retinal diseases, including age-related macular degeneration, diabetic retinopathy, vitreomacular disorders, macular telangiectasia, and inherited retinal dystrophies. In this review, we outline how even subtle disruptions in Müller cells trophism can drive the pathological cascade of Müller cells pathology, emphasizing the need for targeted therapies to preserve retinal health and prevent disease progression.
Keywords: Age-related macular degeneration; Diabetic retinopathy; Inherited retinal dystrophies; Macular teleangectasia; Müller cells; Pathology; Trophism; Vitreomacular disorders.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest All the authors have no relevant disclosures to declare.
Similar articles
-
Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Müller cell ablation.Glia. 2014 Jul;62(7):1110-24. doi: 10.1002/glia.22666. Epub 2014 Mar 31. Glia. 2014. PMID: 24687761
-
Physiology and pathophysiology of the retinal neuroglia.Handb Clin Neurol. 2025;210:239-265. doi: 10.1016/B978-0-443-19102-2.00017-X. Handb Clin Neurol. 2025. PMID: 40148047 Review.
-
Insights on the Regeneration Potential of Müller Glia in the Mammalian Retina.Cells. 2021 Jul 31;10(8):1957. doi: 10.3390/cells10081957. Cells. 2021. PMID: 34440726 Free PMC article. Review.
-
Müller cells and diabetic retinopathy.Vision Res. 2017 Oct;139:93-100. doi: 10.1016/j.visres.2017.03.013. Epub 2017 Sep 5. Vision Res. 2017. PMID: 28866025 Free PMC article. Review.
-
Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells.Elife. 2025 Mar 6;13:RP102151. doi: 10.7554/eLife.102151. Elife. 2025. PMID: 40047533 Free PMC article.
Cited by
-
Resveratrol as a Novel Therapeutic Approach for Diabetic Retinopathy: Molecular Mechanisms, Clinical Potential, and Future Challenges.Molecules. 2025 Aug 4;30(15):3262. doi: 10.3390/molecules30153262. Molecules. 2025. PMID: 40807437 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous